Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma
NCT05532969 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2022-09-27
Summary
It is a single-center, prospective, observational, non-randomized study of newly diagnosed diffuse astrocytoma patients conducted in a tertiary hospital. The investigators conduct an eight-year follow-up, including patients' psychological stress, immune biomarker changes, quality of life, and disease progression of patients towards secondary glioma after the first definite diagnosis. In the first year after diagnosis, patients are followed up four times at 1 month, 3 months, 6 months, and 12 months. After that, patients are followed up semiannually.
The study had two cohorts, a high-stress cohort and a low-stress cohort, which are grouped after initial recruitment. Both groups undergo total resection of tumors and received 3 months of standardized treatment with radiotherapy and chemotherapy. Neither participants nor doctors but the researcher can choose which group participants are in. No one knows if one study group is better or worse than the other.
Conditions
Interventions
- OTHER
-
stressors
Patients are exposed to stressful situations related to the diagnosis and treatment of the disease
Sponsors & Collaborators
-
Henan Provincial People's Hospital
lead OTHER
Principal Investigators
-
Xingyao Bu · Henan Provincial People's Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-20
- Primary Completion
- 2025-12-20
- Completion
- 2026-12-20
Countries
- China
Study Locations
More Related Trials
-
A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators:
NCT06914700 ·Status: COMPLETED
-
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma
NCT05622409 ·Status: RECRUITING
-
The Predictive Value of MRI for Adult-type Diffuse Gliomas
NCT06572592 ·Status: NOT_YET_RECRUITING
-
Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
NCT05541042 ·Status: NOT_YET_RECRUITING
-
Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas
NCT04216537 ·Status: UNKNOWN
-
Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
NCT06015802 ·Status: RECRUITING
-
Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute
NCT02655744 ·Status: RECRUITING
-
Surveillance of Association of Immune Status and Prognosis of CNS Germ Cell Tumor Survivors
NCT04909307 ·Status: UNKNOWN
-
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy
NCT03534050 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes
NCT05635435 ·Status: UNKNOWN
-
Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions
NCT06705036 ·Status: RECRUITING
-
Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
NCT02047058 ·Status: UNKNOWN
-
Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population
NCT05486923 ·Status: COMPLETED
-
PERMA-Based Intervention on Negative Emotions, Adherence, and Complications in Postoperative Glioma Patients
NCT06713395 ·Status: COMPLETED ·Phase: NA
-
Pituitary Tumor Surveillance: Pathogenic Correlation
NCT00599092 ·Status: RECRUITING
-
Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
NCT05990556 ·Status: RECRUITING ·Phase: NA
-
Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus
NCT02536261 ·Status: UNKNOWN
-
Treatment with Intensity Modulated Radiotherapy on the Change of Cognitive Function in Nasopharyngeal Carcinoma Patients: a Prospective Cohort Study
NCT06695936 ·Status: NOT_YET_RECRUITING
-
Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients
NCT05709522 ·Status: UNKNOWN
-
Noninvasively Predicting Gene Status of Glioma
NCT03102112 ·Status: UNKNOWN
-
Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction
NCT07263711 ·Status: RECRUITING
-
Pre-operative Surgical Difficulty Stratification Using Predicted Tumor Perfusion and Consistency
NCT06664190 ·Status: ACTIVE_NOT_RECRUITING
-
The Impact of Anesthesia on High- Grade Glioma Patients
NCT02756312 ·Status: UNKNOWN ·Phase: NA
-
Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost
NCT04006561 ·Status: RECRUITING
-
Prospective Study on Quality of Life in Patients With Intracranial Germ Cell Tumors
NCT05124964 ·Status: RECRUITING